107 related articles for article (PubMed ID: 18022206)
1. Mutations on the N-terminal region abolish differentially the enzymatic activity, membrane-damaging activity and cytotoxicity of Taiwan cobra phospholipase A2.
Chiou YL; Cheng YC; Kao PH; Wang JJ; Chang LS
Toxicon; 2008 Feb; 51(2):270-9. PubMed ID: 18022206
[TBL] [Abstract][Full Text] [Related]
2. Mutations on N-terminal region of Taiwan cobra phospholipase A(2) result in structurally distorted effects.
Chiou YL; Lin SR; Chang LS
J Pept Sci; 2008 Aug; 14(8):890-7. PubMed ID: 18288787
[TBL] [Abstract][Full Text] [Related]
3. Sphingomyelin modulates interfacial binding of Taiwan cobra phospholipase A2.
Chiou YL; Lin SR; Chang LS
Chem Phys Lipids; 2011 Jul; 164(5):378-85. PubMed ID: 21575612
[TBL] [Abstract][Full Text] [Related]
4. The structural and functional contribution of N-terminal region and His-47 on Taiwan cobra phospholipase A2.
Kao PH; Chen KC; Lin SR; Chang LS
J Pept Sci; 2008 Mar; 14(3):342-8. PubMed ID: 18008383
[TBL] [Abstract][Full Text] [Related]
5. Catalytic activity-independent pathway is involved in phospholipase A(2)-induced apoptotic death of human leukemia U937 cells via Ca(2+)-mediated p38 MAPK activation and mitochondrial depolarization.
Liu WH; Kao PH; Chiou YL; Lin SR; Wu MJ; Chang LS
Toxicol Lett; 2009 Mar; 185(2):102-9. PubMed ID: 19118607
[TBL] [Abstract][Full Text] [Related]
6. ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells.
Liu WH; Cheng YC; Chang LS
J Cell Physiol; 2009 Jun; 219(3):642-51. PubMed ID: 19180563
[TBL] [Abstract][Full Text] [Related]
7. Lipid domain formation modulates activities of snake venom phospholipase A(2) enzymes.
Chiou YL; Lin SR; Chang LS
Toxicon; 2010 Dec; 56(8):1362-71. PubMed ID: 20705082
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of Fas and FasL in Taiwan cobra phospholipase A2-treated human neuroblastoma SK-N-SH cells through ROS- and Ca2+-mediated p38 MAPK activation.
Chen KC; Kao PH; Lin SR; Chang LS
J Cell Biochem; 2009 Jan; 106(1):93-102. PubMed ID: 19009558
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence single-molecule study of cobra phospholipase A2 action on a supported gel-phase lipid bilayer.
Chiu CR; Huang WN; Wu WG; Yang TS
Chemphyschem; 2009 Feb; 10(3):549-58. PubMed ID: 19142925
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase A2-interacting weak neurotoxins from venom of monocled cobra Naja kaouthia display cell-specific cytotoxicity.
Mukherjee AK
Toxicon; 2008 Jun; 51(8):1538-43. PubMed ID: 18456298
[TBL] [Abstract][Full Text] [Related]
11. Modification of Lys-6 and Lys-65 affects the structural stability of Taiwan cobra phospholipase A2.
Chang LS; Cheng YC; Chen CP
Protein J; 2006 Feb; 25(2):127-34. PubMed ID: 16862455
[TBL] [Abstract][Full Text] [Related]
12. Roles of lysine residues and N-terminal alpha-amino group in membrane-damaging activity of Taiwan cobra cardiotoxin 3 toward anionic and zwitterionic phospholipid vesicles.
Chiou YL; Kao PH; Liu WH; Lin SR; Chang LS
Toxicon; 2010; 55(2-3):256-64. PubMed ID: 19647762
[TBL] [Abstract][Full Text] [Related]
13. Differential binding to phospholipid bilayers modulates membrane-damaging activity of Naja naja atra cardiotoxins.
Kao PH; Lin SR; Chang LS
Toxicon; 2009 Sep; 54(3):321-8. PubMed ID: 19450618
[TBL] [Abstract][Full Text] [Related]
14. Membrane-bound conformation and phospholipid components modulate membrane-damaging activity of Taiwan cobra cardiotoxins.
Kao PH; Lin SR; Wu MJ; Chang LS
Toxicon; 2009 Apr; 53(5):512-8. PubMed ID: 19673097
[TBL] [Abstract][Full Text] [Related]
15. JNK1/c-Jun and p38 alpha MAPK/ATF-2 pathways are responsible for upregulation of Fas/FasL in human chronic myeloid leukemia K562 cells upon exposure to Taiwan cobra phospholipase A2.
Chen KC; Chiou YL; Chang LS
J Cell Biochem; 2009 Oct; 108(3):612-20. PubMed ID: 19670268
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase A2 activity-independent membrane-damaging effect of notexin.
Kao PH; Lin SR; Chang LS
Toxicon; 2007 Dec; 50(7):952-9. PubMed ID: 17889218
[TBL] [Abstract][Full Text] [Related]
17. Role of the N-terminal region in phospholipases A2 from Naja naja atra (Taiwan cobra) and Naja nigricollis (spitting cobra) venoms.
Yang CC; Chang LS
Toxicon; 1988; 26(8):721-31. PubMed ID: 3188062
[TBL] [Abstract][Full Text] [Related]
18. Nonantibiotic properties of tetracyclines: structural basis for inhibition of secretory phospholipase A2.
Dalm D; Palm GJ; Aleksandrov A; Simonson T; Hinrichs W
J Mol Biol; 2010 Apr; 398(1):83-96. PubMed ID: 20211188
[TBL] [Abstract][Full Text] [Related]
19. Isolation of a snake venom phospholipase A2 (PLA2) inhibitor (AIPLAI) from leaves of Azadirachta indica (Neem): mechanism of PLA2 inhibition by AIPLAI in vitro condition.
Mukherjee AK; Doley R; Saikia D
Toxicon; 2008 Jun; 51(8):1548-53. PubMed ID: 18466944
[TBL] [Abstract][Full Text] [Related]
20. Changes in PLA(2) activity after interacting with anti-inflammatory drugs and model membranes: evidence for the involvement of tryptophan residues.
Gaspar D; Lúcio M; Rocha S; Lima JL; Reis S
Chem Phys Lipids; 2011 May; 164(4):292-9. PubMed ID: 21435339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
